NEOG RSI Chart
Last 7 days
0.2%
Last 30 days
-13.8%
Last 90 days
-26.3%
Trailing 12 Months
-12.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 720.7M | 822.4M | 919.1M | 918.7M |
2022 | 514.5M | 527.2M | 531.2M | 630.7M |
2021 | 450.1M | 468.5M | 487.4M | 503.0M |
2020 | 418.9M | 418.2M | 426.1M | 433.3M |
2019 | 412.5M | 414.2M | 416.0M | 416.7M |
2018 | 388.7M | 397.9M | 403.3M | 409.7M |
2017 | 352.8M | 361.6M | 372.2M | 382.1M |
2016 | 309.8M | 321.3M | 330.1M | 341.2M |
2015 | 271.7M | 283.1M | 290.3M | 301.5M |
2014 | 236.2M | 247.4M | 256.5M | 265.3M |
2013 | 200.1M | 207.5M | 216.3M | 225.2M |
2012 | 179.1M | 184.0M | 188.1M | 193.9M |
2011 | 164.6M | 172.7M | 175.5M | 176.4M |
2010 | 0 | 140.5M | 148.6M | 156.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 03, 2023 | boehm william t | bought | 32,110 | 16.055 | 2,000 | - |
Oct 25, 2023 | jones douglas edward | bought | 151,727 | 15.1727 | 10,000 | chief operating officer |
Oct 13, 2023 | lilly jason warren | sold | -5,300 | 15.1 | -351 | vice president |
Oct 12, 2023 | tobin james p | bought | 45,567 | 15.189 | 3,000 | - |
Oct 11, 2023 | lilly jason warren | sold | -30,087 | 15.6949 | -1,917 | vice president |
Oct 11, 2023 | boehm william t | sold | -40,455 | 15.614 | -2,591 | - |
Oct 11, 2023 | naemura david h. | bought | 150,333 | 15.0333 | 10,000 | cfo |
Aug 18, 2023 | boehm william t | sold | -33,890 | 22.5939 | -1,500 | - |
Aug 18, 2023 | boehm william t | acquired | 23,430 | 15.62 | 1,500 | - |
Apr 25, 2023 | jones douglas edward | sold (taxes) | -4,950 | 16.67 | -297 | chief operating officer |
Which funds bought or sold NEOG recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 26, 2024 | NAPATREE CAPITAL LLC | new | - | 787,729 | 787,729 | 0.79% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -5.64 | 18,619 | 809,630 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 9.3 | 61,522,700 | 393,085,000 | 0.01% |
Mar 04, 2024 | CONGRESS ASSET MANAGEMENT CO /MA | sold off | -100 | -18,739,200 | - | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 7,280 | 7,280 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 60.8 | 25,042,000 | 58,691,200 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -3.06 | 367,064 | 7,493,470 | 0.03% |
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -219,000 | - | -% |
Feb 26, 2024 | Neo Ivy Capital Management | reduced | -99.9 | -162,000 | - | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 116,000 | 1,484,000 | 0.01% |
Unveiling Neogen Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Neogen Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.1B | 23.9B | 38.82 | 7.71 | ||||
IDXX | 44.8B | 3.7B | 53.05 | 12.25 | ||||
A | 43.2B | 6.7B | 34.96 | 6.42 | ||||
DGX | 14.5B | 9.3B | 16.99 | 1.57 | ||||
CRL | 13.8B | 4.1B | 29.14 | 3.35 | ||||
MEDP | 12.4B | 1.9B | 43.86 | 6.58 | ||||
EXAS | 12.1B | 2.5B | -59.47 | 4.86 | ||||
NTRA | 10.9B | 1.1B | -25.12 | 10.09 | ||||
MID-CAP | ||||||||
NEOG | 3.3B | 918.7M | 284.21 | 3.64 | ||||
GH | 2.2B | 563.9M | -4.56 | 3.88 | ||||
SMALL-CAP | ||||||||
CDNA | 544.7M | 280.3M | -2.86 | 1.94 | ||||
ACRS | 89.4M | 31.2M | -1.01 | 2.86 | ||||
AWH | 35.5M | 9.2M | -1.95 | 3.86 | ||||
APDN | 7.3M | 9.0M | -1.01 | 0.81 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Neogen Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 0.3% | 230 | 229 | 242 | 218 | 230 | 132 | 140 | 128 | 131 | 128 | 127 | 117 | 115 | 109 | 109 | 100 | 108 | 101 | 110 | 98.00 | 107 |
Gross Profit | 0.0% | 117 | 117 | 123 | 108 | 113 | 62.00 | 65.00 | 57.00 | 61.00 | 60.00 | 58.00 | 54.00 | 53.00 | 50.00 | 52.00 | 45.00 | 51.00 | 48.00 | 51.00 | 45.00 | 50.00 |
Operating Expenses | 4.8% | 102 | 98.00 | 100 | 92.00 | 120 | 56.00 | 47.00 | 51.00 | 48.00 | 38.00 | 37.00 | 38.00 | 34.00 | 31.00 | 32.00 | 32.00 | 33.00 | 32.00 | 32.00 | 30.00 | 32.00 |
S&GA Expenses | -2.1% | 45.00 | 46.00 | 43.00 | 39.00 | 36.00 | 23.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 19.00 | 18.00 | 17.00 | 16.00 | 18.00 | 18.00 | 18.00 | 18.00 | 17.00 | 18.00 |
R&D Expenses | -14.4% | 6.00 | 7.00 | 7.00 | 7.00 | 7.00 | 5.00 | 4.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 |
EBITDA Margin | 39.3% | 0.13* | 0.09* | 0.13* | 0.08* | 0.07* | 0.13* | 0.16* | 0.17* | 0.19* | 0.20* | 0.21* | - | - | - | - | - | - | - | - | - | - |
Income Taxes | -262.5% | -0.26 | 0.00 | 2.00 | -10.45 | 8.00 | 1.00 | 4.00 | 1.00 | 2.00 | 5.00 | 4.00 | 3.00 | 3.00 | 4.00 | 5.00 | 2.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 |
Earnings Before Taxes | -325.3% | -3.75 | 2.00 | 8.00 | -2.26 | -34.09 | 7.00 | 19.00 | 7.00 | 13.00 | 22.00 | 20.00 | 16.00 | 19.00 | 20.00 | 21.00 | 14.00 | 19.00 | 18.00 | 19.00 | 17.00 | 20.00 |
EBT Margin | 112.2% | 0.00* | -0.03* | -0.03* | -0.01* | 0.00* | 0.08* | 0.11* | 0.12* | 0.14* | 0.16* | 0.16* | 0.17* | 0.17* | 0.17* | 0.17* | 0.17* | 0.18* | 0.18* | 0.18* | - | - |
Net Income | -332.0% | -3.49 | 2.00 | 6.00 | 8.00 | -41.84 | 5.00 | 15.00 | 5.00 | 11.00 | 17.00 | 16.00 | 13.00 | 16.00 | 16.00 | 16.00 | 12.00 | 16.00 | 15.00 | 16.00 | 13.00 | 16.00 |
Net Income Margin | 144.3% | 0.01* | -0.03* | -0.03* | -0.02* | -0.03* | 0.07* | 0.09* | 0.10* | 0.11* | 0.13* | 0.13* | 0.14* | 0.14* | 0.14* | 0.14* | 0.14* | 0.14* | 0.14* | 0.15* | - | - |
Free Cashflow | -31.7% | 16.00 | 23.00 | 91.00 | -17.07 | -18.73 | -14.14 | 20.00 | 7.00 | 18.00 | 23.00 | 22.00 | 12.00 | 22.00 | 25.00 | 26.00 | 20.00 | 17.00 | 24.00 | 21.00 | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 0.9% | 4,602 | 4,561 | 4,554 | 4,561 | 4,563 | 977 | 993 | 981 | 968 | 932 | 920 | 880 | 846 | 822 | 797 | 774 | 751 | 721 | 696 | 673 | 660 |
Current Assets | 7.0% | 624 | 584 | 586 | 555 | 643 | 608 | 627 | 610 | 611 | 609 | 591 | 555 | 578 | 557 | 537 | 515 | 500 | 474 | 450 | 423 | 414 |
Cash Equivalents | 15.1% | 206 | 179 | 163 | 67.00 | 100 | 107 | 44.00 | 43.00 | 51.00 | 71.00 | 76.00 | 73.00 | 114 | 61.00 | 66.00 | 51.00 | 66.00 | 56.00 | 42.00 | 94.00 | 102 |
Inventory | 14.1% | 161 | 141 | 134 | 144 | 136 | 129 | 122 | 113 | 107 | 102 | 101 | 99.00 | 93.00 | 98.00 | 95.00 | 89.00 | 86.00 | 88.00 | 86.00 | 85.00 | 79.00 |
Net PPE | 10.5% | 244 | 221 | 199 | 165 | 148 | 121 | 111 | 105 | 101 | 100 | 100 | 98.00 | 84.00 | 81.00 | 79.00 | 78.00 | 77.00 | 75.00 | 75.00 | 76.00 | 74.00 |
Goodwill | 0.0% | 2,138 | 2,138 | 2,137 | 2,135 | 2,122 | 1,975 | 143 | 150 | 143 | 130 | 131 | 133 | 112 | 112 | 110 | 110 | 104 | 103 | 104 | 104 | 103 |
Liabilities | 2.8% | 1,455 | 1,415 | 1,420 | 1,383 | 1,457 | 94.00 | 106 | 106 | 101 | 77.00 | 80.00 | 73.00 | 68.00 | 70.00 | 72.00 | 62.00 | 60.00 | 61.00 | 58.00 | 53.00 | 58.00 |
Current Liabilities | 27.9% | 177 | 138 | 145 | 107 | 153 | 67.00 | 78.00 | 66.00 | 63.00 | 51.00 | 54.00 | 46.00 | 45.00 | 46.00 | 48.00 | 39.00 | 39.00 | 40.00 | 38.00 | 34.00 | 39.00 |
Long Term Debt | 0.1% | 887 | 886 | 885 | 885 | 924 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.1% | 887 | 886 | 885 | 885 | 924 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 0.0% | 3,148 | 3,146 | 3,134 | 3,126 | 3,106 | 884 | 887 | 876 | 865 | 855 | 840 | 808 | 777 | 752 | 725 | 712 | 691 | 660 | 638 | 620 | 602 |
Retained Earnings | -0.6% | 563 | 567 | 565 | 559 | 551 | 593 | 588 | 573 | 568 | 557 | 540 | 524 | 510 | 495 | 479 | 462 | 450 | 434 | 419 | 403 | 390 |
Additional Paid-In Capital | 0.1% | 2,575 | 2,572 | 2,568 | 2,565 | 2,561 | 313 | 310 | 308 | 305 | 298 | 295 | 290 | 273 | 264 | 249 | 255 | 244 | 232 | 222 | 217 | 216 |
Accumulated Depreciation | - | - | - | 120 | - | - | - | 105 | - | - | - | 98.00 | - | - | - | 75.00 | - | - | - | 66.00 | - | - |
Shares Outstanding | 0.1% | 217 | 216 | 216 | 216 | 162 | 108 | 108 | 108 | 108 | 107 | 106 | 107 | 106 | 106 | 105 | 106 | 105 | 105 | 104 | - | - |
Float | - | - | - | - | - | 3,572 | - | - | - | 4,325 | - | - | - | 3,952 | - | - | - | 3,489 | - | - | - | 3,378 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -31.7% | 15,714 | 23,009 | 90,966 | -17,069 | -18,726 | -14,143 | 20,390 | 6,591 | 17,847 | 23,210 | 21,969 | 11,596 | 22,390 | 25,134 | 25,628 | 19,778 | 16,753 | 23,719 | 20,877 | 10,382 | 16,501 |
Share Based Compensation | 33.1% | 3,512 | 2,638 | 2,866 | 2,812 | 2,632 | 1,867 | 2,109 | 1,607 | 1,748 | 1,690 | 1,664 | 1,581 | 1,511 | 1,681 | 1,673 | 1,640 | 1,612 | 1,543 | 1,406 | 1,306 | 1,400 |
Cashflow From Investing | 232.8% | 11,536 | -8,684 | 6,876 | 19,523 | 93,002 | 81,638 | -17,099 | -15,386 | -39,337 | -25,407 | -31,710 | -60,918 | 22,796 | -35,732 | -12,208 | -42,951 | -18,265 | -15,361 | -75,515 | -20,361 | -15,698 |
Cashflow From Financing | -129.2% | -310 | 1,062 | 252 | -39,977 | -79,261 | 905 | -1,029 | 1,223 | 5,571 | 1,048 | 10,743 | 10,143 | 7,563 | 5,095 | 1,490 | 8,702 | 10,505 | 8,708 | 3,282 | 349 | 1,276 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Nov. 30, 2023 | Nov. 30, 2022 | Nov. 30, 2023 | Nov. 30, 2022 | |
Revenues | ||||
Total revenue | $ 229,629 | $ 230,033 | $ 458,616 | $ 362,382 |
Cost of Revenues | ||||
Total Cost of Revenues | 112,855 | 117,494 | 225,081 | 187,573 |
Gross Profit | 116,774 | 112,539 | 233,535 | 174,809 |
Operating Expenses | ||||
Sales and marketing | 44,832 | 36,348 | 90,615 | 59,731 |
General and administrative | 51,721 | 77,001 | 96,842 | 104,945 |
Research and development | 5,756 | 6,846 | 12,478 | 11,727 |
Total Operating Expenses | 102,309 | 120,195 | 199,935 | 176,403 |
Operating Income (Loss) | 14,465 | (7,656) | 33,600 | (1,594) |
Other Expense | ||||
Interest income | 1,863 | 553 | 3,653 | 1,523 |
Interest expense | (18,032) | (20,545) | (36,488) | (20,547) |
Other expense | (2,043) | (6,443) | (2,849) | (6,814) |
Total Other Expense | (18,212) | (26,435) | (35,684) | (25,838) |
Loss Before Taxes | (3,747) | (34,091) | (2,084) | (27,432) |
Provision for Income Taxes | (260) | 7,750 | (100) | 9,200 |
Net Loss | $ (3,487) | $ (41,841) | $ (1,984) | $ (36,632) |
Net Loss Per Share | ||||
Basic | $ (0.02) | $ (0.19) | $ (0.01) | $ (0.23) |
Diluted | $ (0.02) | $ (0.19) | $ (0.01) | $ (0.23) |
Weighted Average Shares Outstanding | ||||
Basic | 216,410,493 | 216,134,350 | 216,359,511 | 161,689,929 |
Diluted | 216,410,493 | 216,134,350 | 216,359,511 | 161,689,929 |
Product Revenues | ||||
Revenues | ||||
Total revenue | $ 203,869 | $ 203,317 | $ 408,270 | $ 310,109 |
Cost of Revenues | ||||
Total Cost of Revenues | 98,353 | 102,530 | 195,312 | 157,971 |
Service Revenues | ||||
Revenues | ||||
Total revenue | 25,760 | 26,716 | 50,346 | 52,273 |
Cost of Revenues | ||||
Total Cost of Revenues | $ 14,502 | $ 14,964 | $ 29,769 | $ 29,602 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Nov. 30, 2023 | May 31, 2023 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 205,765 | $ 163,240 |
Marketable securities | 24,501 | 82,329 |
Accounts receivable, net of allowance of $3,403 and $2,827 | 150,498 | 153,253 |
Inventories, net | 160,529 | 133,812 |
Prepaid expenses and other current assets | 83,080 | 53,297 |
Total Current Assets | 624,373 | 585,931 |
Net Property and Equipment | 244,300 | 198,749 |
Other Assets | ||
Right of use assets | 15,015 | 11,933 |
Goodwill | 2,137,983 | 2,137,496 |
Intangible assets, net | 1,564,744 | 1,605,103 |
Other non-current assets | 16,000 | 15,220 |
Total Assets | 4,602,415 | 4,554,432 |
Current Liabilities | ||
Current portion of finance lease | 2,569 | |
Accounts payable | 112,184 | 76,669 |
Accrued compensation | 15,642 | 25,153 |
Income tax payable | 10,217 | 6,951 |
Accrued interest | 10,985 | 11,149 |
Deferred revenue | 4,679 | 4,616 |
Other accruals | 20,336 | 20,934 |
Total Current Liabilities | 176,612 | 145,472 |
Deferred Income Tax Liability | 355,005 | 353,427 |
Non-Current Debt | 886,915 | 885,439 |
Other Non-Current Liabilities | 36,316 | 35,877 |
Total Liabilities | 1,454,848 | 1,420,215 |
Commitments and Contingencies (note 12) | ||
Equity | ||
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding | 0 | 0 |
Common stock, $0.16 par value, 315,000,000 shares authorized, 216,520,296 and 216,245,501 shares issued and outstanding at November 30, 2023, and May 31, 2023, respectively | 34,644 | 34,599 |
Additional paid-in capital | 2,574,994 | 2,567,828 |
Accumulated other comprehensive loss | (25,128) | (33,251) |
Retained earnings | 563,057 | 565,041 |
Total Stockholders' Equity | 3,147,567 | 3,134,217 |
Total Liabilities and Stockholders' Equity | $ 4,602,415 | $ 4,554,432 |
 | Mr. John Edward Adent |
---|---|
 | www.neogen.com |
 | 2640 |